The Board also approved the acquisition of an additional stake of upto 4.83% of JC Biotech (existing 85% subsidiary) [JC Biotech] by way of purchase of upto 1,000,000 equity shares from one of the existing shareholder of JC Biotech at a total consideration not exceeding Rs. 6.8 crore.

The Board approved the conversion of loan including interest, as was earlier granted by the Company to Advanced Enzymes Europe B.V., Netherlands, an existing wholly owned subsidiary of the Company [AEE] into equity shares of AEE (further acquisition of equity shares in AEE).